Rui Shen

机构：Chinese University of Hong Kong, Shenzhen, Xi'an Chest Hospital, Wuhan University of Science and Technology · ORCID：0000-0002-9186-0078

发表论文 113 篇 · 总被引 3130 次 · h-index 24

代表论文

• Global Evolution of Environmental and Social Disclosure in Annual Reports (2024 · Journal of Accounting Research · 被引 79)
• Capital market internationalization and firms' ESG performance: Evidence from the inclusion of China A-shares in the MSCI Emerging Market Index (2024 · Energy Economics · 被引 48)
• GLP-1 receptor agonist attenuates tubular cell ferroptosis in diabetes via enhancing AMPK-fatty acid metabolism pathway through macropinocytosis (2024 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 被引 36)
• Steering the Intangible Wheel: Chief Executive Officer Effect on Corporate Cultural Change (2024 · Organization Science · 被引 20)
• PPARα/δ dual agonist H11 alleviates diabetic kidney injury by improving the metabolic disorders of tubular epithelial cells (2024 · Biochemical Pharmacology · 被引 12)
• Ultrasound-derived fat fraction for the noninvasive quantification of hepatic steatosis: a prospective multicenter study (2025 · Insights into Imaging · 被引 7)